Table 3.
Attitude of the physicians of both groups regarding pharmacovigilance.
| Doctors attending CME | Doctors not attending CME | |
|---|---|---|
| Sources used to gather information about ADRs | ||
| Textbooks | 38 | 40 |
| Journals | 69 | 42* |
| Medical representatives | 7 | 17** |
| Internet | 63 | 49 |
| Seminar/conferences | 65 | 22# |
| Drug promotional literature | 9 | 26* |
| ADRs reported till now | ||
| None | 77 | 68 |
| 1–5 | 15 | 25 |
| 6–10 | 1 | 7 |
| 15–20 | 4 | — |
| 1 | — | |
| Free access to ADR reporting form | 63 | 19# |
| Information was clear on the form | 58 | 14# |
| Need for training on filling of ADR reporting form | 90 | 82 |
| Method preferred for reporting ADR information | ||
| Direct contact | 40 | 32 |
| Telephone | 26 | 25 |
| 44 | 54 | |
| Self | 15 | 7 |
| Other | 17 | 4* |
*P < 0.005; # P < 0.0001; **P < 0.05; ## P < 0.001.